DealForma Research

Recent Articles

Endocrine, Metabolic R&D Partnerships, M&A and Ventures by Tech – H1 2024 Review

October 2, 2024

September 2023 Top Biopharma Deal: Immatics development and commercialization deal with Moderna for TCR therapies

October 2, 2023

Endocrine And Metabolic Disease Biopharma R&D Partnerships In 2023

September 29, 2023

Neurology Venture Activity Through Q2 2023

September 15, 2023

Cerebral Alliances: A Closer Look At Neurology R&D Partnerships In H1 2023

September 8, 2023

August 2023 Top Biopharma Deal: Poseida license option deal with Astellas for P-MUC1C-ALLO1

September 5, 2023

Biopharma IPO Watch: Therapeutics & Platforms

August 30, 2023

Q2 2023 Biopharma Venture Funding – Therapeutics and Platforms

August 21, 2023

Q2 2023 Review Of R&D Partnerships For Biopharma Therapeutics & Platforms

August 14, 2023

M&A In Biopharma Therapeutics & Platforms – Q2 2023

August 4, 2023

July 2023 Top Biopharma Deal: Alnylam co-development and co-commercialization deal with Roche for zilebesiran

August 1, 2023

Healthcare & Life Sciences Sector: Quarterly Overview

August 1, 2023

Neurology M&A Snapshot Through Q2 2023

July 15, 2023

All of this by stage, disease indication, modality, target…

+ 0 k

Licensing Deals

+ 0 k

M&A

+ 0 k

Other Deals

+ 0 k

Funding Rounds

+ 0 k

Company Profiles

+ 0 k

Drug Sales Figures